Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frank Haluska, M.D., Ph.D.
Ariad Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago Hospitals, Section of Hematology/oncology
Chicago, Illinois, United States
- Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place
St Louis, Missouri, United States
- the Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- New York Presbyterian Hospital, Weill College of Cornell University
New York, New York, United States
- Morris Cancer Center - Duke University Medical Center, Adult Bone Marrow Transplant Clinic
Durham, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Jeane'S Hospital of Tuhs
Philadelphia, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2004
- Primary completion
- 30 Jun 2006
- Completion
- 30 Jun 2006
- Last update posted
- 19 Aug 2015
- Registered enrollment
- 57
- Registry id
- NCT00086125
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.